Strides Pharma Science Limited has informed the Exchange regarding a press release dated July 04, 2023, titled "Stelis Biopharma enters into a binding term sheet with Syngene International Limited to divest its Unit 3 multi-modal facility for a gross consideration of INR 7,020 million".
Press Release Jul 04 2023
Filed with NSE · · 3 pages · English
Release
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release May 25 2023
- Press Release May 19 2023
- Press Release May 03 2023
- Press Release Feb 24 2023
- Earnings Update_Q2FY23
Later from Strides Pharma Science
- Intimation of Board Meeting scheduled on August 2, 2023
- Press Release Aug 02 2023
- Press Release Aug 30 2023
- Press Release Sep 09 2023
- Press Release Sep 14 2023
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science